Scholars@Duke

Subclassification of Type 2 Diabetes Paves the Way for Personalized Outcome Prediction and Patient Management.

Publication ,  Journal Article
Wei, R; Colón-Franco, JM
Published in: Clin Chem
March 31, 2021
Published version (DOI) Open Access Copy (Duke) Link to item

Duke Scholars

Ruhan Wei
Author Ruhan Wei Pathology

Published In

Clin Chem

DOI

10.1093/clinchem/hvab003

EISSN

1530-8561

Publication Date

March 31, 2021

Volume

67

Issue

4

Start / End Page

701

Location

England

Related Subject Headings

  • General Clinical Medicine
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
  • 1004 Medical Biotechnology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wei, R., & Colón-Franco, J. M. (2021). Subclassification of Type 2 Diabetes Paves the Way for Personalized Outcome Prediction and Patient Management. Clin Chem, 67(4), 701. https://doi.org/10.1093/clinchem/hvab003
Wei, Ruhan, and Jessica M. Colón-Franco. “Subclassification of Type 2 Diabetes Paves the Way for Personalized Outcome Prediction and Patient Management.” Clin Chem 67, no. 4 (March 31, 2021): 701. https://doi.org/10.1093/clinchem/hvab003.
Wei, Ruhan, and Jessica M. Colón-Franco. “Subclassification of Type 2 Diabetes Paves the Way for Personalized Outcome Prediction and Patient Management.” Clin Chem, vol. 67, no. 4, Mar. 2021, p. 701. Pubmed, doi:10.1093/clinchem/hvab003.

Published In

Clin Chem

DOI

10.1093/clinchem/hvab003

EISSN

1530-8561

Publication Date

March 31, 2021

Volume

67

Issue

4

Start / End Page

701

Location

England

Related Subject Headings

  • General Clinical Medicine
  • 3205 Medical biochemistry and metabolomics
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
  • 1101 Medical Biochemistry and Metabolomics
  • 1004 Medical Biotechnology